Issued Patents All Time
Showing 1–25 of 31 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10183039 | Methods for the production of collagen IV | Christopher Cummings, Gautam Bhave, A. Scott McCall | 2019-01-22 |
| 9289417 | Compounds and methods for the modulation of sulfilimine bond formation | Roberto Vanacore, Gautam Bhave, Vadim Pedchenko | 2016-03-22 |
| 7122517 | Crystallized structure of type IV collagen NC1 domain hexamer | Munirathinam Sundaramoorthy | 2006-10-17 |
| 7030146 | Methods for treating diabetic neuropathy | John W. Baynes, Suzanne R. Thorpe, Thorsten Degenhardt, Raja Khalifah, Nathan Alderson | 2006-04-18 |
| 6750209 | Advanced glycation end-product intermediaries and post-amadori inhibition | Parvin Todd, Raja Khalifah, Aaron Ashley Booth | 2004-06-15 |
| 6740668 | Methods for inhibiting diabetic complications | John W. Baynes, Suzanne R. Thorpe, Thorsten Degenhardt, Raja Khalifah, Nathan Alderson | 2004-05-25 |
| 6730686 | Methods for inhibiting oxidative modification of proteins | John W. Baynes, Joelle Onorato, Suzanne R. Thorpe, Raja Khalifah | 2004-05-04 |
| 6716858 | Methods for inhibiting diabetic complications | Raja Khalifah | 2004-04-06 |
| 6689746 | Use of isolated domains of type IV collagen to modify cell and tissue interactions | Michael P. Sarras, Jr. | 2004-02-10 |
| 6680293 | Use of isolated domains of type IV collagen to modify cell and tissue interactions | Michael P. Sarras, Jr. | 2004-01-20 |
| 6521645 | Methods for the treatment and prevention of urinary stone disease | Paul Voziyan, Jon Scheimman | 2003-02-18 |
| 6498140 | Use of isolated domains of type IV collagen to modify cell and tissue interactions | Michael P. Sarras, Jr. | 2002-12-24 |
| 6472411 | Advanced glycation end-product intermediaries and post-amadori inhibition | Parvin Todd, Raja Khalifah, Aaron Ashley Booth | 2002-10-29 |
| 6472400 | Advanced gylcation end-product intermediaries and post-Amadori inhibition | Parvin Todd, Raja Khalifah, Aaron Ashley Booth | 2002-10-29 |
| 6448222 | Use of isolated alpha 2 domain of type IV collagen to modify cell and tissue interactions | Michael P. Sarras, Jr. | 2002-09-10 |
| 6440729 | Treating angiogenesis-mediated diseases with the &agr;2 monomer of type IV collagen | Michael P. Sarras, Jr. | 2002-08-27 |
| 6436969 | Dialysis solutions and methods | Raja Khalifah | 2002-08-20 |
| 6432706 | Method for inhibiting angiogenesis and tumors with the isolated NC1 &agr;6 chain monomer of type IV collagen | Michael P. Sarras, Jr. | 2002-08-13 |
| 6419924 | Antibodies of isolated domains of type IV collagen modify cell interactions | Michael P. Sarras, Jr. | 2002-07-16 |
| 6384012 | Use of isolated domains of type IV collagen to modify cell and tissue interactions | Michael P. Sarras, Jr. | 2002-05-07 |
| 6361994 | Method for inhibiting angiogenesis and tumors with the isolated NC1 &agr;1 chain monomer of type IV collagen | Michael P. Sarras, Jr. | 2002-03-26 |
| 6358735 | Method for inhibiting angiogenesis and tumors with the isolated NC1 &agr;3 chain monomer of type IV collagen | Michael P. Sarras, Jr. | 2002-03-19 |
| 6277558 | .alpha.-3 chain type IV collagen polynucleotides | — | 2001-08-21 |
| 6228858 | Advanced glycation end-product intermediaries and post-amadori inhibition | Parvin Todd, Raja Khalifah, Aaron Ashley Booth | 2001-05-08 |
| 6007980 | Alpha-3 chain type IV collagen polypeptides | Stephen T. Reeders, Karen E. Morrison | 1999-12-28 |